HJ Science Co., Ltd. Class H (6132) AI Stock Analysis

HJ Science Co., Ltd. Class H

(HKEX:6132)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Negative Factors

HJ Science Co., Ltd. Class H (6132) vs. iShares MSCI Hong Kong ETF (EWH)

Market Cap: HKD 2.44B
Dividend Yield: ―
Average Volume (3M): 93.73K
Price to Earnings (P/E): -23.9
Beta (1Y): 0.66
Revenue Growth: ―
EPS Growth: ―
Country: Hong Kong
Employees: 113
Sector: General
Sector Strength: 55
Industry: Biotechnology

HJ Science Co., Ltd. Class H Business Overview & Revenue Model

Company Description

HJ Science Co., Ltd. is a clinical stage biotech company, which engages in research and development of small molecule drugs for tumors, autoimmune & metabolic system diseases for clinical treatments. It provides drug design, in vivo and in vitro acti...

HJ Science Co., Ltd. Class H Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

HK:6132 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:6998	70Outperform	HKD 3.12B	4.31	10.99%	―	1417.68%	660.14%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
HK:2181	51Neutral	HKD 1.81B	18.26	48.25%	―	88.38%	―
HK:1541	44Neutral	HKD 1.18B	-4.49	-32.32%	―	28.93%	27.27%
HK:3681	43Neutral	HKD 1.40B	-6.42	-41.81%	―	―	-4.24%

* General Sector Average

Performance Comparison

HK:6132 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
HK:6132	HJ Science Co., Ltd. Class H	33.14	-2.12	-6.01%
HK:6998	Genor Biopharma Holdings Limited	1.55	-1.74	-52.74%
HK:2181	Mabpharm Limited	0.44	-0.08	-15.38%
HK:3681	SinoMab Bioscience Ltd.	1.00	-0.77	-43.50%
HK:2105	Laekna, Inc.	6.60	-5.36	-44.82%
HK:1541	ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H	2.80	-4.85	-63.40%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

HJ Science Co., Ltd. Class H AI Stock Analysis